María Teresa Valenzuela

Author

Also Known As

M T Valenzuela, M Teresa Valenzuela, M Teresa Valenzuela B, M. Eugenia Valenzuela M, M. Teresa Valenzuela, M. Teresa Valenzuela B, M. Teresa Valenzuela B., M. Valenzuela, M.T. Valenzuela, M.Teresa Valenzuela

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Universidad de Los Andes, Chile University of Chile World Health Organization Regional Office for the Americas Hospital Luis Calvo Mackenna Sabin Vaccine Institute

About

María Teresa Valenzuela is an author at Universidad de Los Andes, Chile specializing in medicine, epidemiology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	658
2	Public Health	4	4	344
3	Business	1	1	12
4	Allergy	1	1	98
5	Economics	1	1	12

María Teresa Valenzuela

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study Marı́a Elena Santolaya, Miguel L. O’Ryan, María Teresa Valenzuela, The Lancet VaccinationVaccine SafetyHealthy AdolescentsPhase 2B/3Placebo-controlled Study	2012	262
Clinical presentation of Bacillus Calmette-Guérin infections in patients with immunodeficiency syndromes. B González, Santiago Moreno, R Burdach, PubMed Bcg InfectionBcg VaccinationImmunodeficienciesImmunologyClinical Presentation	1989	98
Persistence of antibodies in adolescents 18−24 months after immunization with one, two, or three doses of 4CMenB meningococcal serogroup B vaccine Marı́a Elena Santolaya, Miguel O’Ryan, María Teresa Valenzuela, Human Vaccines & Immunotherapeutics	2013	82
Two year review of intestinal intussusception in six large public hospitals of Santiago, Chile Miguel O’Ryan, Yalda Lucero, Alfredo Peña, The Pediatric Infectious Disease Journal	2003	71
Population-based surveillance for hospitalized and ambulatory pediatric invasive pneumococcal disease in Santiago, Chile Rosanna Lagos, Alma Muñoz, María Teresa Valenzuela, The Pediatric Infectious Disease Journal	2002	66
Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens Rosanna Lagos, María Teresa Valenzuela, Orin S. Levine, The Lancet VaccinationRandomised TrialTwo-dose RegimensVaccine EfficacyInfection Control	1998	60
Crosstalk between PARP-1 and NF-κB modulates the promotion of skin neoplasia David Martín‐Oliva, Francisco O′Valle, José Antonio Muñoz‐Gámez, Oncogene InflammationCutaneous BiologyImmune RegulationImmunologyPathology	2004	59
Cost-effectiveness of universal childhood hepatitis A vaccination in Chile María Teresa Valenzuela, R. Jake Jacobs, Óscar Arteaga, Vaccine VaccinationUniversal Childhood HepatitisPreventive MedicineHealth EconomicsHepatitis	2005	56
Cost-effectiveness of pneumococcal conjugate vaccination in Latin America and the Caribbean: a regional analysis Anushua Sinha, Dagna Constenla, J.E. Valencia, Revista Panamericana de Salud Pública	2008	53
Effectiveness of the 10-Valent Pneumococcal Conjugate Vaccine (PCV-10) in Children in Chile: A Nested Case-Control Study Using Nationwide Pneumonia Morbidity and Mortality Surveillance Data Janepsy Díaz, Solana Terrazas, Ana Luiza Bierrenbach, PLoS ONE	2016	42

Page 1